UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Environmental impacts and risks of the national renewable energy targets – A review and a qualitative case study from Finland

Renewable & sustainable energy reviews, 2018-02, Vol.82, p.1433-1441

2018

Volltextzugriff (PDF)

Environmental impacts of the national renewable energy targets – A case study from Finland

Renewable & sustainable energy reviews, 2016-06, Vol.59, p.1599-1610

2016

Volltextzugriff (PDF)

Life cycle assessment of a new smart label for intelligent packaging

Flexible and printed electronics, 2024-03, Vol.9 (1)

2024

Volltextzugriff (PDF)

0950 Simulated Knowledge Work Decreases Alertness in Job-burnout

Sleep (New York, N.Y.), 2018-04, Vol.41 (suppl_1), p.A352-A353

2018

Volltextzugriff (PDF)

Stocks and flows of nitrogen and phosphorus in the Finnish food production and consumption system

Agriculture, ecosystems & environment, 2005-05, Vol.107 (2), p.287-305

2005

Volltextzugriff (PDF)

Municipal solid waste production and composition in Finland—Changes in the period 1960–2002 and prospects until 2020

Resources, conservation and recycling, 2007-06, Vol.50 (4), p.475-488

2007

Volltextzugriff (PDF)

Bruce/apollon promotes hippocampal neuron survival and is downregulated by kainic acid

Biochemical and biophysical research communications, 2005-12, Vol.338 (2), p.729-735

2005

Volltextzugriff (PDF)

Cost-Utility Analysis (Cua) of First-Line Actinic Keratosis (Ak) Treatments in Finland

Value in health, 2014-11, Vol.17 (7), p.A609-A609

2014

Volltextzugriff (PDF)

Dexamethasone regulates expression of BRUCE/Apollon and the proliferation of neural progenitor cells

FEBS letters, 2009-07, Vol.583 (13), p.2213-2217

2009

Volltextzugriff (PDF)

Cavernosal nerve functionality evaluation after magnetic resonance imaging-guided transurethral ultrasound treatment of the prostate

World journal of radiology, 2015-12, Vol.7 (12), p.521-530

2015

Volltextzugriff (PDF)

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2024-03, Vol.76 (3), p.363-376

2024

Volltextzugriff (PDF)

Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011

Clinical and experimental rheumatology, 2023-01, Vol.41 (1), p.151

2023

Volltextzugriff (PDF)

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Annals of the rheumatic diseases, 2023-06, Vol.82 (6), p.820-828

2023

Volltextzugriff (PDF)

Chromatin modifier developmental pluripotency associated factor 4 (DPPA4) is a candidate gene for alcohol-induced developmental disorders

BMC medicine, 2022-12, Vol.20 (1), p.495-25, Article 495

2022

Volltextzugriff (PDF)

Disease burden measured by patient-reported outcomes: does psoriatic arthritis feel worse than rheumatoid arthritis? A cross-sectional nationwide study

Clinical and experimental rheumatology, 2023-11, Vol.41 (11), p.2177

2023

Volltextzugriff (PDF)

Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.935-942

2011

Volltextzugriff (PDF)

AB0164 ARE PATIENTS WITH RA IN REMISSION IN FINLAND DURING THE COVID TIMES? RESULTS FROM THE FINNISH QUALITY REGISTER

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1212-1212

2022

Volltextzugriff (PDF)

AB0168 DISEASE BURDEN MEASURED BY PROs: DOES PSORIATIC ARTHRITIS (PsA) FEEL WORSE THAN RHEUMATOID ARTHRITIS (RA)? A CROSS-SECTIONAL STUDY

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1213-1214

2022

Volltextzugriff (PDF)

The validity of rheumatoid arthritis diagnoses in Finnish biobanks

Scandinavian journal of rheumatology, 2023-01, Vol.52 (1), p.1-9

2023

Volltextzugriff (PDF)

The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register

Pediatric rheumatology online journal, 2023-04, Vol.21 (1), p.35-35, Article 35

2023

Volltextzugriff (PDF)

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Annals of the rheumatic diseases, 2023, Vol.82 (10), p.1286-1295

2023

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(87)
Tagungsberichte
(7)

Sprache

Englisch
(94)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(47)
Humans
(37)
Rheumatology
(36)
Rheumatoid Arthritis
(27)
Female
(22)
Medicin Och Hälsovetenskap
(22)
Male
(20)
Biological And Medical Sciences
(18)
Middle Aged
(18)
Medical Sciences
(16)
Arthritis, Rheumatoid - Drug Therapy
(15)
Diseases Of The Osteoarticular System
(14)
Patients
(14)
Antirheumatic Agents - Therapeutic Use
(13)
Inflammatory Joint Diseases
(13)
Severity Of Illness Index
(11)
Adult
(10)
Monoclonal Antibodies
(10)
Aged
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Environmental impacts and risks of the national renewable energy targets – A review and a qualitative case study from Finland

Environmental impacts of the national renewable energy targets – A case study from Finland

Life cycle assessment of a new smart label for intelligent packaging

0950 Simulated Knowledge Work Decreases Alertness in Job-burnout

Stocks and flows of nitrogen and phosphorus in the Finnish food production and consumption system

Municipal solid waste production and composition in Finland—Changes in the period 1960–2002 and prospects until 2020

Bruce/apollon promotes hippocampal neuron survival and is downregulated by kainic acid

Cost-Utility Analysis (Cua) of First-Line Actinic Keratosis (Ak) Treatments in Finland

Dexamethasone regulates expression of BRUCE/Apollon and the proliferation of neural progenitor cells

Cavernosal nerve functionality evaluation after magnetic resonance imaging-guided transurethral ultrasound treatment of the prostate

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Real-world data on seropositive rheumatoid arthritis, then and now: ten-year outcomes of 1151 patients diagnosed between 1997 and 2011

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Chromatin modifier developmental pluripotency associated factor 4 (DPPA4) is a candidate gene for alcohol-induced developmental disorders

Disease burden measured by patient-reported outcomes: does psoriatic arthritis feel worse than rheumatoid arthritis? A cross-sectional nationwide study

Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative

AB0164 ARE PATIENTS WITH RA IN REMISSION IN FINLAND DURING THE COVID TIMES? RESULTS FROM THE FINNISH QUALITY REGISTER

AB0168 DISEASE BURDEN MEASURED BY PROs: DOES PSORIATIC ARTHRITIS (PsA) FEEL WORSE THAN RHEUMATOID ARTHRITIS (RA)? A CROSS-SECTIONAL STUDY

The validity of rheumatoid arthritis diagnoses in Finnish biobanks

Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial

The feasibility of existing JADAS10 cut-off values in clinical practice: a study of data from The Finnish Rheumatology Quality Register

Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Suchergebnisse filtern